Oncology \u00b7 HRT
HRT during and after cancer treatment
HRT during or after cancer treatment is nuanced. Some cancers preclude systemic estrogen; many don't. Every decision is a shared one with oncology.
Key points
- Coordinate with oncology
- Consider non-hormonal first-line
- Vaginal DHEA/estrogen for GSM if approved
Frequently asked questions
Which cancers preclude HRT?
ER-positive breast cancer typically. Ovarian, cervical, colon, thyroid generally don't.
What about vaginal estrogen?
Often acceptable with oncology sign-off — even in some breast cancer survivors.
Non-hormonal alternatives?
Fezolinetant, SSRIs, gabapentin, CBT.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.